Dominik Thor is President of the Geneva College of Longevity Science (GCLS), the world's first higher education institution dedicated exclusively to longevity science. Under his leadership, GCLS has built a portfolio of pioneering academic and clinical education programmes, including one of the first Executive Master of Science degrees in longevity science, internationally attended physician education initiatives, and CME-accredited continuing medical education in preventive and healthspan-oriented medicine.

Together with Ovidius University of Constanța, GCLS has launched the world's first doctoral programme in Medicine with a specialization in Longevity Sciences. GCLS has also become a collaborative institution within the Qatar National Precision Ageing and Functional Longevity Programme for Healthy Ageing, where Dominik leads the education and framework development workstream.
An internationally recognized speaker on longevity innovation, technology, and policy, Dominik is actively shaping the academic, clinical, and strategic development of the field. His work centres on building the institutional and clinical frameworks needed to advance longevity medicine into a credible, scalable, and evidence-based medical discipline — bridging academia, healthcare systems, and policy across regions.

He serves as Chair of the GCLS Semester Symposium and Co-Chair of international scientific events connecting experts across Europe, Asia, and the GCC. He holds the position of Professor of Pharmacy at GCLS, Visiting Professor at the University of Medicine and Pharmacy Carol Davila in Bucharest, and Co-Director of the first PhD programme in Medicine specializing in Longevity Sciences.

Dominik holds a background in biomaterials and regenerative medicine and is an active scientific author and contributor to the development of longevity education and policy internationally.